{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:06:53Z","timestamp":1770437213375,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.4158\/ep.14.2.213","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:07:48Z","timestamp":1365199668000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Multidisciplinary Approach including Receptor Radionuclide Therapy with 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-OCTREOTIDE) and 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3]-OCTREOTATE) in Ectopic Cushing Syndrome from Ametastatic Gastrinoma: A Promising Proposal"],"prefix":"10.1016","volume":"14","author":[{"given":"Maria Vittoria","family":"Dav\u00ec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ferdeghini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Oliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Lo","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Francia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.2.213_bb0005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0039-6060(05)80123-0","article-title":"Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas","volume":"18","author":"Amikura","year":"1995","journal-title":"Surgery."},{"key":"10.4158\/EP.14.2.213_bb0010","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.213_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.14.2.213_bb0020","first-page":"752","article-title":"Ectopic adrenocorticotropic hormone syndrome [published correction appears in Endocr Rev. 1995;16:507]","volume":"15","author":"Wajchenberg","year":"1994","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.14.2.213_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.190.1.8259429","article-title":"Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant?","volume":"190","author":"Doppman","year":"1994","journal-title":"Radiology."},{"key":"10.4158\/EP.14.2.213_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushing\u2019s syndrome in patients with the Zollinger-Ellison syndrome","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.14.2.213_bb0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","article-title":"The diagnosis and management of advanced neuroendocrine tumors","volume":"25","author":"Kaltas","year":"2004","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.14.2.213_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjsurg.2003.04.007","article-title":"Management of neuroendocrine liver metastases","volume":"187","author":"Sutcliffe","year":"2004","journal-title":"Am J Surg."},{"key":"10.4158\/EP.14.2.213_bb0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00268-001-0032-5","article-title":"Cushing syndrome due to ectopic adrenocorticotropic hormone secretion","volume":"25","author":"Aniszewski","year":"2001","journal-title":"World J Surg."},{"issue":"Suppl 1","key":"10.4158\/EP.14.2.213_bb0050","first-page":"62S","article-title":"Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs","volume":"46","author":"Kwekkeboom","year":"2005","journal-title":"J Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0055","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00259-004-1571-4","article-title":"Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours","volume":"31","author":"Bodei","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.4158\/EP.14.2.213_bb0060","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0065","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors","volume":"23","author":"Kwekkeboom","year":"2005","journal-title":"J Clin Oncol."},{"issue":"Suppl 1","key":"10.4158\/EP.14.2.213_bb0070","first-page":"13S","article-title":"Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs","volume":"46","author":"de Jong","year":"2005","journal-title":"J Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0075","first-page":"1310","article-title":"Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC","volume":"46","author":"Forrer","year":"2005","journal-title":"J Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002590100490","article-title":"Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide","volume":"28","author":"Paganelli","year":"2001","journal-title":"Eur J Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/snuc.2002.31563","article-title":"Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyroctreotide: the experience of the European Institute of Oncology Group","volume":"32","author":"Chinol","year":"2002","journal-title":"Semin Nucl Med."},{"key":"10.4158\/EP.14.2.213_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/jcp.39.9.955","article-title":"Immunocytochemical study of 18 tumours causing ectopic Cushing\u2019s syndrome","volume":"39","author":"Coates","year":"1986","journal-title":"J Clin Pathol."},{"key":"10.4158\/EP.14.2.213_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome","volume":"17","author":"Yu","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.4158\/EP.14.2.213_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4158\/ep.9.3.229","article-title":"Cushing\u2019s syndrome from ectopic production of corticotropin by a metastatic gastrinoma","volume":"9","author":"Babu","year":"2003","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.14.2.213_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)01471-1","article-title":"Low-dose hypersensitivity: current status and possible mechanisms","volume":"49","author":"Joiner","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20428848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/W6J018QUW2385226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:06Z","timestamp":1761515286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20428848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1530891X20428848"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.2.213","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary Approach including Receptor Radionuclide Therapy with 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-OCTREOTIDE) and 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3]-OCTREOTATE) in Ectopic Cushing Syndrome from Ametastatic Gastrinoma: A Promising Proposal","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.2.213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}